UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments

Neurology : neuroimmunology & neuroinflammation, 2022-01, Vol.9 (1)

2022

Volltextzugriff (PDF)

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

PloS one, 2016-06, Vol.11 (6), p.e0158156

2016

Volltextzugriff (PDF)

Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV

Immunity (Cambridge, Mass.), 2017-06, Vol.46 (6), p.1005-1017.e5

2017

Volltextzugriff (PDF)

Hybrid Virtual Screening Approach to Predict Novel Natural Compounds against HIV‑1 CCR5

The journal of physical chemistry. B, 2024-07, Vol.128 (29), p.7086-7101

2024

Volltextzugriff (PDF)

Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis

Expert opinion on investigational drugs, 2018-03, Vol.27 (3), p.301-311

Tacke, Frank

2018

Volltextzugriff (PDF)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Frontiers in immunology, 2022-01, Vol.12, p.816515

2022

Volltextzugriff (PDF)

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

Cancer research (Chicago, Ill.), 2018-04, Vol.78 (7), p.1657-1671

2018

Volltextzugriff (PDF)

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

Neuropharmacology, 2016-09, Vol.108, p.207-219

2016

Volltextzugriff (PDF)

CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma

The Journal of experimental medicine, 2022-05, Vol.219 (5)

2022

Volltextzugriff (PDF)

Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice

Journal of hepatology, 2018-09, Vol.69 (3), p.676-686

2018

Volltextzugriff (PDF)

Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges

Expert opinion on investigational drugs, 2020-02, Vol.29 (2), p.89-92

2020

Volltextzugriff (PDF)

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

Acta pharmacologica Sinica, 2023-10, Vol.44 (10), p.1935-1947

2023

Volltextzugriff (PDF)

Co-receptor signaling in the pathogenesis of neuroHIV

Retrovirology, 2021-08, Vol.18 (1), p.24-24, Article 24

2021

Volltextzugriff (PDF)

A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model

International journal of molecular sciences, 2024-07, Vol.25 (13), p.7410

2024

Volltextzugriff (PDF)

Involvement of CCR5 on interstitial macrophages in the development of lung fibrosis in severe asthma

International immunopharmacology, 2024-06, Vol.135, p.112331-112331, Article 112331

2024

Volltextzugriff (PDF)

Dopamine receptor activation increases HIV entry into primary human macrophages

PloS one, 2014-09, Vol.9 (9), p.e108232

2014

Volltextzugriff (PDF)

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

AIDS (London), 2022-01, Vol.36 (1), p.11-18

2022

Volltextzugriff (PDF)

CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1

Biochemical pharmacology, 2022-01, Vol.195, p.114859-114859, Article 114859

2022

Volltextzugriff (PDF)

CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth

Haematologica (Roma), 2019-03, Vol.104 (3), p.564-575

2019

Volltextzugriff (PDF)

Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells

European journal of immunology, 2024-07, Vol.54 (7), p.e2350847-n/a

2024

Volltextzugriff (PDF)

A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands

British journal of pharmacology, 2014-07, Vol.171 (14), p.3364-3375

2014

Volltextzugriff (PDF)

Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV‑1 Activities and Improved Oral Bioavailability

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16526-16540

2022

Volltextzugriff (PDF)

Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist

Brain, behavior, and immunity, 2020-01, Vol.83, p.288-292

2020

Volltextzugriff (PDF)

Paradoxical anxiolytic effect of the ‘bath salt’ synthetic cathinone MDPV during early abstinence is inhibited by a chemokine CXCR4 or CCR5 receptor antagonist

Drug and alcohol dependence, 2022-01, Vol.230, p.109204-109204, Article 109204

2022

Volltextzugriff (PDF)

Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations

Journal of neuroinflammation, 2020-10, Vol.17 (1), p.296-296, Article 296

2020

Volltextzugriff (PDF)

1 – 25 von 1.006

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(933)
Mit Volltextzugriff
(820)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(892)
Life Sciences & Biomedicine
(826)
Humans
(815)
Ccr5 Receptor Antagonists
(654)
Pharmacology & Pharmacy
(414)
Animals
(394)
Hiv-1 - Drug Effects
(332)
Receptors, Ccr5 - Metabolism
(331)
Anti-Hiv Agents - Pharmacology
(325)
Biological And Medical Sciences
(314)
Hiv Infections - Drug Therapy
(296)
Medical Sciences
(288)
Pharmacology. Drug Treatments
(229)
Human Immunodeficiency Virus 1
(224)
Hiv
(205)
Human Immunodeficiency Virus
(202)
Antiviral Agents
(201)
Infectious Diseases
(195)
Male
(187)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(179)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(992)
EZB Electronic Journals Library
(520)
IngentaConnect_期刊（NSTL购买）
(438)
Journals@Ovid
(299)
IngentaConnect Journals
(250)
Elsevier ScienceDirect Journals
(230)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(199)
Standalone journals
(180)
Wiley Online Library Journals
(103)
Wiley Online Library Full Collection 2018
(72)
Taylor & Francis Journals
(65)
Taylor & Francis
(60)
Taylor & Francis Journals Complete
(53)
SpringerLink_现刊
(48)
Oxford journals
(39)
Nexis Uni
(28)
SAGE Journals
(28)
Oxford Journals 2020 Medicine
(27)
JSTOR
(23)
Nature
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV

Hybrid Virtual Screening Approach to Predict Novel Natural Compounds against HIV‑1 CCR5

Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma

Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice

Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

Co-receptor signaling in the pathogenesis of neuroHIV

A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model

Involvement of CCR5 on interstitial macrophages in the development of lung fibrosis in severe asthma

Dopamine receptor activation increases HIV entry into primary human macrophages

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1

CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth

Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells

A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands

Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV‑1 Activities and Improved Oral Bioavailability

Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist

Paradoxical anxiolytic effect of the ‘bath salt’ synthetic cathinone MDPV during early abstinence is inhibited by a chemokine CXCR4 or CCR5 receptor antagonist

Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations

Suchergebnisse filtern